Chi-Med, Eli Lil­ly score a land­mark ap­proval in Chi­na for the first new can­cer drug de­vel­oped in Chi­na

Hutchi­son Chi­na MediTech CEO Chris­t­ian Hogg just nabbed im­por­tant brag­ging rights to the first full ap­proval of a ma­jor can­cer drug that was made in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.